Cholesteryl ester transfer protein: at the heart of the action of lipid-modulating therapy with statins, fibrates, niacin, and cholesteryl ester transfer protein inhibitors by M. John Chapman, Wilfried Le Goff, Maryse Guerin, and Anatol Kontush EHJ Volume 31(2): January 14, 2010 Published on behalf of the European Society of Cardiology. All rights reserved. © The Author For permissions please
Pathways of reverse cholesterol transport in man. M. John Chapman et al. Eur Heart J 2010;31: Published on behalf of the European Society of Cardiology. All rights reserved. © The Author For permissions please
Comparison of pathways of cholesteryl ester transfer protein-mediated heterotransfer of neutral core lipids between lipoprotein particles in normotriglyceridaemia vs. mixed dyslipidaemia involving moderate to marked hypertriglyceridaemia and subnormal levels of triglyceride- enriched high-density lipoprotein. M. John Chapman et al. Eur Heart J 2010;31: Published on behalf of the European Society of Cardiology. All rights reserved. © The Author For permissions please
Cardiovascular risk remains high despite aggressive statin therapy. M. John Chapman et al. Eur Heart J 2010;31: Published on behalf of the European Society of Cardiology. All rights reserved. © The Author For permissions please